Evidence map›Paper›PMID 42221412›Full record

ArticleAACE endocrinology and diabetes

A Rare Case of Acromegaly and Prolactinoma in MEN4 Caused by a CDKN1B Mutation.

Liu Yuke, Wang Hongxing, Tan Huiwen, Li Jianwei, Yu Yerong

Abstract readCase Reports
In one paragraph

Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liu YukeDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Wang HongxingDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Tan HuiwenDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Li JianweiDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Yu YerongDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Objective: Multiple endocrine neoplasia (MEN) comprises a group of rare autosomal dominant genetic disorders characterized by the development of benign or malignant tumors in 2 or more endocrine glands, most commonly including the thyroid, parathyroid, pituitary, adrenal glands, and pancreatic neuroendocrine tissues. MEN4 is a recently recognized subtype that phenotypically overlaps with MEN1 and is caused by germline mutations in the cyclin-dependent kinase inhibitor 1B (CDKN1B) gene. However, due to the limited number of reported cases and the lack of standardized clinical guidelines, the clinical characteristics of MEN4 remain insufficiently understood. Case report: A 59-year-old female presented to our department with progressive facial changes for over 8 years and a pituitary mass detected 6 months prior. Whole-exome sequencing identified pathogenic mutations in the CDKN1B gene, confirming the diagnosis of MEN4. Conclusion: We report a rare case of MEN4 presenting with acromegaly, hyperparathyroidism, and papillary thyroid cancer, caused by a CDKN1B mutation. This case highlights the phenotypic diversity of MEN4 and underscores the importance of genetic testing in patients with overlapping endocrine neoplasms. We also added a literature review to raise clinical awareness of MEN 4 and improve management.

Indexed as

acromegalyCDKN1Bhyperparathyroidismhyperprolactinemiamultiple endocrine neoplasiapituitary neuroendocrine tumors

Identifiers

PMID42221412
PMCPMC13221923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.